HOME >> MEDICINE >> NEWS
Panel offers guidelines on skin reactions to new class of cancer drugs

DURHAM, N.C., May 22 -- Skin reactions to a powerful new class of anti-cancer drugs are frequent, but manageable through a simple and rational treatment approach usually without the need to reduce the dose or interrupt treatment with potentially life-prolonging chemotherapy, according to an article in the May issue of "The Oncologist."

The special article presents the first recommendations on skin reactions to the new drugs, called Epidermal Growth Factor Receptor Inhibitors (EGFRIs). The guidelines were developed at an international multidisciplinary meeting, including medical oncologists, dermatologists, nurses, and pharmacists. "One important goal is to ensure that healthcare professionals and patients see EGFRI-associated dermatologic toxicity as manageable, thereby optimizing clinical benefit from continued and uninterrupted use of EGFRIs when possible," according to lead author Dr. Thomas J. Lynch, Jr., of Massachusetts General Hospital, Boston.

Treatment with EGFRIs has been shown to improve survival in patients with several types of cancer, including lung, pancreatic, and colorectal cancers. The drugs including erlotinib (Tarceva), cetuximab (Erbitux), and panitumumab (Vectibix) work by interfering with cell-signaling abnormalities that contribute to cancer development and growth.

Unfortunately, the EGFRIs carry a substantial risk of skin reactions more than half of treated patients have some type of skin toxicity, most commonly an acne-like rash. The reactions most likely occur because the receptor blocked by the drugs also performs key functions in normal skin. There is even evidence that the rash may be a sign that EGFRI anti-cancer treatment is working in some studies, patients with more severe skin reactions had better survival. The skin reactions are rarely so severe that the dosage is reduced or treatment stopped. Until recently, there was no strong scientific data to guide the treatment of skin reactions to EGFRIs
'"/>

Contact: George Kendall
gkendall@alphamedpress.com
919-680-0011
AlphaMed Press, Inc.
23-May-2007


Page: 1 2 3

Related medicine news :

1. Panel offers expert analysis on causes, prevention of stent thrombosis
2. Panel presents Agricultural Biosecurity & Sustainability Strategies at 2007 AAAS Meeting
3. Panel updates guidelines for treatment of adult HIV infection
4. Panel finds insufficient evidence to recommend for or against maternal-request Caesarean delivery
5. Panel calls for a new look at treatments commonly used for chronic insomnia
6. Hormone therapy offers new hope for ovarian cancer patients
7. TB test offers patients quicker and easier diagnosis
8. Supersize me mice research offers grim warning for Americas fast food consumers
9. New treatment offers relief from chronic back pain
10. Commonly used drug offers promise for premature babies
11. Stenting of abdominal arteries offers welcome relief for intestinal angina

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/1/2020)... ... April 01, 2020 , ... American hospital workers are ... Coronavirus-infected patients. , Staffers are in particular need of face shields, which protect ... The Wall Street Journal reported that New York City mayor Bill de Blasio's ...
(Date:3/30/2020)... DIEGO (PRWEB) , ... March 30, 2020 , ... ... to new and prospective patients, continuing its commitment to provide comprehensive and compassionate ... , Patients can use Achieve Medical Center’s UpDox platform for telemedicine services including ...
(Date:3/28/2020)... ... March 27, 2020 , ... ... the public from the spread of the coronavirus. Operating under the designation as ... forward with infrastructure renewal and environmental protection projects in the downstate New York ...
(Date:3/28/2020)... ... March 28, 2020 , ... ... Therapy Services (EPPTS), a physical therapist-owned rehabilitation company since 1985 specializing in the ... TX. , “Since we started more than 30 years ago, we have been ...
(Date:3/27/2020)... VEGAS (PRWEB) , ... March 27, 2020 , ... During a time of global distress ... merchant processing, is donating to the UNITE HERE Education and Support Fund in ... pandemic. , UNITE HERE represents 300,000 working people in the food ...
Breaking Medicine News(10 mins):
(Date:3/27/2020)... ... March 27, 2020 , ... ... and families, is changing its name to Nexus Family Healing. For more than ... for youth and families suffering from mental, emotional and behavioral issues. Moving forward, ...
(Date:3/27/2020)... ... March 27, 2020 , ... A ... based on students' holistic portfolios, revealed that college-bound young adults are reconsidering their ... creating huge new barriers to high school senior’s path to college and possibly ...
(Date:3/27/2020)... ... March 27, 2020 , ... PTS Diagnostics, a U.S.-based manufacturer ... as President and Chief Executive Officer. , Mr. Chapman brings 20 years of ... ARKRAY USA, Inc. He joins PTS Diagnostics with an accomplished track record regarding ...
Breaking Medicine Technology:
Cached News: